Presenting author
Yanina Flossbach
2 presentations
W24. Seltorexant versus quetiapine extended release as adjunctive treatment in major depressive disorder with insomnia symptoms: Phase 3 trial
PS01-1117. Metabolic profiles of participants with major depressive disorder with insomnia symptoms: phase-3 trial of seltorexant versus quetiapine-XR as adjunctive therapy